Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Preclinical Probes for Oncology

  • You have access
    Determination of the radioimmunoreactivity for anti-CD66-antibody therapy
    Gordon Winter, Jessica Loeffler, Gabriel Fischer, Christoph Solbach, Peter Kletting, Ambros Beer and Gerhard Glatting
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1478;
  • You have access
    C-C Chemokine Receptor Type 2-Targeting Ultrasmall Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma
    Xiaohui Zhang, Lisa Detering, Deborah Sultan, Hannah Luehmann, Lin Li, Gyu Seong Heo, Xiuli Zhang, Lanlan Lou, Patrick Grierson, Suellen Greco, Marianna Ruzinova, Richard Laforest, Farrokh Dehdashti, Kian-Huat Lim and Yongjian Liu
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1469;
  • You have access
    Baseline 18F fluorodeoxyglucose(FDG)-positron emission tomography (PET) in patient derived (PD) xenograft models from the National Cancer Institute Patient Derived Model Repository (PDMR).
    Paula Jacobs, James Tatum, Joseph Kalen, Lisa Riffle, Nimit Patel, Jessica Phillips, Melinda Hollingshead, Yvonne Evrard, Michelle Gottholm-Ahalt, Chelsea Sanders, Simone Difilippantonio and James Doroshow
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1470;
  • You have access
    PET imaging of PD-L1 using anti-PD-L1-B11 antibody in breast cancer tumor model
    Aditya Bansal, Whitney Barham, Xin Liu, Susan Harrington, Fabrice Lucien-Matteoni, Haidong Dong, Sean Park, Mukesh Pandey and Timothy DeGrado
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1486;
  • You have access
    99mTc-HYNIC-diabody targeting transferrin receptor for tumor imaging
    Yong He and Lei Dai
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1502;
  • You have access
    PET Imaging and Biodistribution of 64Cu-DOTA-Atezolizumab in Mice Bearing MDA-MB231 Xenograft
    Vinod Nagarajan, Seri Park, Deok Il Kim, Sang-Keun Woo and ILHAN LIM
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1490;
  • You have access
    Preclinical assessment of nanoparticles conjugated with 64Cu-DOTA-PEG-BBN targeting gastrin-releasing peptide receptors
    Livia Elena Chilug, Alexandrina Nan, Radu Anton Leonte, Ramona Daniela Dusman, Antero Abrunhosa, Gina Manda, Rodica Turcu and Dana Niculae
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1508;
  • You have access
    Chelator free Ga-68/Gd co-labeling ultra-small gold nanorod for colorectal cancers PET-MRI diagnosis and image-guided radiotherapy
    Lu Zhang and Changjing Zuo
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1488;
  • You have access
    Initial biological evaluations of [18F]KS1, ascorbate-based ROS imaging ligand in tumor models of non-human primates.
    Naresh Damuka, Greg Dugan, Ashley Davis, Buddhika Liyana Pathirannahel, John Puckett, Michael Moore, Gagan Deep, Avinash Bansode, Akiva Mintz, Cristina Furdui, Mark Cline and Kiran Kumar Solingapuram Sai
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1480;

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
SNMMI

© 2025 SNMMI

Powered by HighWire